Renalytix plc Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q2 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Renalytix plc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q2 2018 to Q2 2024.
  • Renalytix plc Deferred Tax Assets, Valuation Allowance for the quarter ending June 30, 2024 was $55.4M, a 21.6% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $55.4M +$9.84M +21.6% Jun 30, 2024 10-K 2024-09-30
Q2 2023 $45.6M +$14.5M +46.6% Jun 30, 2023 10-K 2024-09-30
Q2 2022 $31.1M +$10.1M +47.8% Jun 30, 2022 10-K 2023-09-28
Q2 2021 $21M +$13.7M +187% Jun 30, 2021 20-F 2022-10-31
Q2 2020 $7.33M +$2.33M +46.6% Jun 30, 2020 20-F 2022-10-31
Q2 2019 $5M +$4.83M +2912% Jun 30, 2019 20-F/A 2022-08-01
Q2 2018 $166K Jun 30, 2018 20-F/A 2020-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.